Cormorant Asset Management, LP Diversified Active

Location: Boston, MA

CIK: 0001583977 · Show all filings

Period: Q4 2013 (Next →)

Filing Date: Feb 14, 2014

Total Value: $345M (100.0% shares, 0.0% debt)

Holdings (37)

MEDIVATION INC 10.1%
Value $34.9M Shares 546,900 Est. Cost $63.82 Unrealized
CUBIST PHARMACEUTICALS INC 8.0%
Value $27.55M Shares 400,000 Est. Cost $68.87 Unrealized
KERYX BIOPHARMACEUTICALS 6.4%
Value $22.02M Shares 1,700,000 Est. Cost $12.95 Unrealized
DYAX CORP 6.2%
Value $21.48M Shares 2,850,000 Est. Cost $7.54 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 6.0%
Value $20.71M Shares 200,000 Est. Cost $58.69 Unrealized 0.0%
CELGENE CORP 5.9%
Value $20.28M Shares 120,000 Est. Cost $168.97 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value $19.99M Shares 800,000 Est. Cost $23.59 Unrealized 0.0%
IDENIX PHARMACEUTICALS INC 5.1%
Value $17.49M Shares 2,925,000 Est. Cost $5.98 Unrealized
GERN GERON CORP 4.7%
Value $16.1M Shares 3,397,156 Est. Cost $4.29 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 4.7%
Value $16.07M Shares 250,000 Est. Cost $59.65 Unrealized 0.0%
BMY BRISTOL-MYERS SQUIBB CO 4.2%
Value $14.35M Shares 270,000 Est. Cost $34.16 Unrealized 0.0%
ARROWHEAD RESEARCH CORP 3.1%
Value $10.8M Shares 995,500 Est. Cost $10.85 Unrealized
DXCM DEXCOM INC 3.1%
Value $10.62M Shares 300,000 Est. Cost $7.91 Unrealized 0.0%
RECEPTOS INC 2.9%
Value $10.15M Shares 350,000 Est. Cost $28.99 Unrealized
ARRAY BIOPHARMA INC 2.5%
Value $8.768M Shares 1,750,000 Est. Cost $5.01 Unrealized
ACELRX PHARMACEUTICALS INC 2.5%
Value $8.483M Shares 750,000 Est. Cost $11.31 Unrealized
TESARO INC 2.5%
Value $8.472M Shares 300,000 Est. Cost $28.24 Unrealized
CLOVIS ONCOLOGY INC 2.1%
Value $7.19M Shares 119,300 Est. Cost $60.27 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 2.0%
Value $7.035M Shares 100,000 Est. Cost $67.90 Unrealized 0.0%
ALKERMES PLC 1.8%
Value $6.099M Shares 150,000 Est. Cost $40.66 Unrealized
AMAG PHARMACEUTICALS INC 1.8%
Value $6.07M Shares 250,000 Est. Cost $24.28 Unrealized
PODD INSULET CORP 1.6%
Value $5.565M Shares 150,000 Est. Cost $36.94 Unrealized 0.0%
NOVAVAX INC 1.5%
Value $5.12M Shares 1,000,000 Est. Cost $5.12 Unrealized
PCRX PACIRA PHARMACEUTICALS INC 0.8%
Value $2.875M Shares 50,000 Est. Cost $52.58 Unrealized 0.0%
SGMO SANGAMO BIOSCIENCES INC 0.7%
Value $2.309M Shares 166,200 Est. Cost $11.51 Unrealized 0.0%
KARYOPHARM THERAPEUTICS INC 0.7%
Value $2.292M Shares 100,000 Est. Cost $22.92 Unrealized
CHIMERIX INC 0.6%
Value $2.161M Shares 143,000 Est. Cost $15.11 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.6%
Value $2.037M Shares 268,000 Est. Cost $6.33 Unrealized 0.0%
PORTOLA PHARMACEUTICALS INC 0.6%
Value $1.931M Shares 75,000 Est. Cost $25.75 Unrealized
OSIRIS THERAPEUTICS INC NEW 0.5%
Value $1.733M Shares 107,800 Est. Cost $16.08 Unrealized
XENOPORT INC 0.3%
Value $1.15M Shares 200,000 Est. Cost $5.75 Unrealized
REGULUS THERAPEUTICS INC 0.2%
Value $739K Shares 100,000 Est. Cost $7.39 Unrealized
MOMENTA PHARMACEUTICALS INC 0.1%
Value $490K Shares 27,700 Est. Cost $17.69 Unrealized
PTCT PTC THERAPEUTICS INC 0.1%
Value $489K Shares 28,800 Est. Cost $17.58 Unrealized 0.0%
DENDREON CORP 0.1%
Value $449K Shares 150,000 Est. Cost $2.99 Unrealized
FIVE PRIME THERAPEUTICS INC 0.1%
Value $336K Shares 20,000 Est. Cost $16.80 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.1%
Value $273K Shares 10,000 Est. Cost $24.23 Unrealized 0.0%